Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Hagerstown. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Hagerstown at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
Age-related macular degeneration (AMD) affects millions of elderly patients. When advanced, there is Geographic Atrophy (GA) in the retina. This means that there is an area with a loss of light-sensitive cells, called photoreceptors. That part of the retina can no longer see. Atrophy begins as a small spot in the retina distant from the fovea which is the part of the retina responsible for sharp central vision. The GA grows, and when it reaches the fovea, vision is severely diminished, and detai
Sponsor: Galimedix Therapeutics Inc
Check if you qualify for this macular degeneration clinical trial in Hagerstown, MD
If you're searching for macular degeneration treatment options in Hagerstown, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hagerstown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.